Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2001-12-17
2010-10-12
Ford, Vanessa L. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S184100, C424S190100, C530S300000, C530S324000
Reexamination Certificate
active
07811592
ABSTRACT:
The instant invention relates to antigens and nucleic acids encoding such antigens obtainable by screening aChlamydiagenome. In more specific aspects, the invention relates to methods of isolating such antigens and nucleic acids and to methods of using such isolated antigens for producing immune responses. The ability of an antigen to produce an immune response may be employed in vaccination or antibody preparation techniques.
REFERENCES:
patent: 5212062 (1993-05-01), Daniels et al.
patent: 5703057 (1997-12-01), Johnston et al.
patent: 5989553 (1999-11-01), Johnston et al.
patent: 6559294 (2003-05-01), Griffais et al.
patent: 9928475 (1999-06-01), None
patent: WO99/28475 (1999-06-01), None
patent: WO 99/28475 (1999-06-01), None
patent: 9953948 (1999-10-01), None
patent: WO 99/53948 (1999-10-01), None
patent: 02053588 (2002-07-01), None
patent: WO 02/053588 (2002-07-01), None
Thomas E. Creighton, in his book, “Proteins: Structures and Molecular Properties, 1984”, (p. 315).
Thomas E. Creighton, in his book “Protein Structure: A Practical Approach, 1989; pp. 184-186”.
Nosoh, Y. et al in “Protein Stability and Stabilization through Protein Engineering, 1991” (chapter 7, p. 197, second paragraph).
Kalenboeck et al (FASEB Journal , Apr. 2000, vol. 14, No. 6, p. A1130, meetings held May 12-16, 2000)(Abstract).
Thomas E. Creighton, in his book, “Proteins: Structures and Molecular Properties, 1984”, (p. 315).
Thomas E. Creighton, in his book “Protein Structure: A Practical Approach, 1989; pp. 184-186”.
Nosoh, Y. et al in “Protein Stability and Stabilization through Protein Engineering, 1991” (chapter 7, p. 197, second paragraph).
McHenry (Molecular Microbiology 2003, 49(5), 1157-1165).
Curnow et al (Proc. Natl. Acad. Sci., vol. 94, Oct. 1997, p. 11819-11826).
Raczniak et al (The Journal of Biological Chemistry).
Sato et al (Science, vol. 273, Jul. 19, 1996, p. 352-354).
Kaltenboeck et al., “Fully protective vaccine candidate genes ofChlamydia psittaciidentified by random expression library immunization,”FASEB J., 14:A1130, abstract # 146.6, 2000.
Kaltenboeck et al., “Use of synthetic antigens improves detection by enzyme-linked immunoabsorbent assay of antibodies against abortigenicChlamydia psittaciin ruminants,”J. Clin. Micrbiol., 35:2293-2298, 1997.
B. Kaltenboeck et al Poster: “Fully Protective Vaccine Candidate Genes ofChlamydia pittaciIdentified by Random Expression Library Immunization”.
Stephens et al., “Genome sequence of an obligate intracellular pathogen of humans:Chlamydia trachomatis,” Science, 282:754-759, 1998.
Sykes and Johnston, “Genetic live vaccines mimic the antigenicity but not pathogenicity of live viruses,”DNA Cell. Biol., 18(7):521-531, 1999.
Tan, et al., “Protection of sheep againstChlamydia psittaciinfection with a subcellular vaccine containing the major outer membrane protein,”Infect Immun, 58:3101-3108, 1990.
Tang et al., “Genetic immunization is a simple method for eliciting an immune response,”Nature, 356:152-154, 1992.
Ulmer and Liu, “ELI's coming: expression library and vaccine antigen discovery,”Comment Viewpoint.
Vanrompay et al., “Protection of turkeys againstChlamydia psittacichalleng by gene gun-based DNA immunizations,”Vaccine, 17:2628-2635, 1999.
Vanrompay et al., “Protection of turkeys againstChlamydophila psittacichallenge by parenteral and mucosal inoculations and the effect of turkey interferon-gamma on genetic immunization,” Immunology, 103:106-112, 2001.
Vanrompay et al., “Turkeys are protected from infection withChlamydia psittaciby plasmid DNA vaccination against the major outer membrane protein,”Clin. Exp. Immunol., 118:49-55, 1999.
Co-pending U.S. Appl. No. 09/738,269 by Stephen A. Johnston et al., filed Dec. 15, 2000.
Alberti et al., “Specific cellular and humoral immune response in Balb/c mice immunised with an expression genomic library ofTrypanosoma cruzi,” Vaccine, 16(6):608-612, 1998.
Babiuk, “Broadening the approaches to developing more effective vaccines,”Vaccine, 17:1587-1895, 1999.
Barry et al., “Protection against mycoplasma infection using expression-library immunization,”Nature, 377:632-635, 1995.
Brayton et al., “Expression library immunization to identify protective antigens fromCowdria ruminantium,” Ann. NY Acad. Sci., 849:369-371, 1998.
Ellis, “New technologies for making vaccines,”Vaccine, 17:1596-1604, 1999.
Feltquate, et al., “Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization,”J Immunol, 158:2278-2284, 1997.
Huang, et al., “IL-12 administered duringChlamydia psittacilung infection in mice confers immediate and long-term protection and reduces MIP-2 level and neutrophil infiltration in lung tissue,”J. Immunol., 162:2217-2226, 1999.
Johnston and Barry, “Genetic to genomic vaccination,”Vaccine, 15(8):808-809, 1997.
Kalman et al., “Comparative genomes ofChlamydia pneumoniaeandC. trachomatis,” Nature Genetics, 21:385-389, 1999.
Kaltenbock et al., “Genetically determined vigorous innate immunity is associated with protection against primary chlamydial lung infection in mice, but with profound disease exacerbation in reinfection,”In Chlamydial Infections: Proceedings of the 9th International Symposium on Human Chlamydial Infection, E. A. R. Stephens, ed., 1998.
Kaltenbock et al., “Evidence for numerous omp 1 alleles of porcineChlamydia trachomatisand novel chlamydial species obtained by PCR,”J. Clin. Microbiol., 35:1835-1841, 1997.
Kaltenboeck et al., “Structures of and allelic diversity and relationships among the major outer membrane protein (ompA) genes of the four chlamydial species,”J Bacteriol., 175(2):487-502, 1993.
Longbottom et al., “Identification of a multigene familiy coding for the 90 kDa proteins of the ovine abortion subtype ofChlamydia psittaci,” FEMS Microbiology Letters, 142:277-281, 1996.
Longbottom, et al., “Molecular cloning and characterization of the genes coding for the highly immunogenic cluster of 90-kilodalton envelope proteins from theChlamydia psittacisubtype that causes abortion in sheep,”Infect Immun, 66:1317-1324, 1998.
Manoutcharian et al., “Protection against murine cysticercosis using cDNA expression library immunization,”Immunol. Lett., 62:131-136, 1998.
Meijer et al. “Genomic relatedness ofChlamydiaisolates determined by amplified fragment length polymorphism analysis,”J. Bacteriology, 181:4469-4475, 1999.
Morrison, et al., “Gene knockout mice establish a primary protective role for major histocmpatibility complex class II-restricted responses inChlamydia trachomatisgenital tract infection,”Infect. Immun., 63:4661-4668, 1995.
Piedrafita et al., “Protective immune response induced by vaccination with an expression genomic library ofLeishmania major,” Journal of Immunology, 163:1467-1472, 1998.
Rottenberg, et al., “Role of innate and adaptive immunity in the outcome of primary infection withChlamydia pneumoniae, as analyzed in genetically modified mice,”J. Immunol., 162:2829-2836, 1999.
Sanford, et al., “An improved, helium-driven biolistic device,”Technique, 3:3-16, 1991.
Smooker et al., “Expression library immunization protects mice against a challenge with virulent rodent malaria,”Vaccine, 18:2533-2540, 2000.
Stephens et al., “Genome sequence of an obligate intracellular pathogen of humans:Chlamydia trachomatis,” Science, 282:754-759, 1998.
Sykes and Johnston, “Genetic live vaccines mimic the antigenicity but not pathogenicity of live viruses,”DNA Cell. Biol., 18(7):521-531, 1999.
Tan, et al., “Protection of sheep againstChlamydia psittaciinfection with a subcellular vaccine con
Johnston Stephen A.
Kaltenboeck Bernhard
Stemke-Hale Katherine
Sykes Kathryn F.
Andrus Sceales Starke & Sawall LLP
Auburn University
Board of Regents , The University of Texas System
Ford Vanessa L.
LandOfFree
Methods and compositions for vaccination comprising nucleic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for vaccination comprising nucleic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for vaccination comprising nucleic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4161754